Bajaj Healthcare
Bajaj Healthcare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Bajaj Healthcare
Start SIPBajaj Healthcare Investment Rating
-
Master Rating:
-
Bajaj Healthcare has an operating revenue of Rs. 673.29 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 9% is okay, ROE of 11% is good. The company has a reasonable debt to equity of 25%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 158 | 142 | 201 | 172 | 176 |
| Operating Expenses Qtr Cr | 139 | 113 | 168 | 146 | 151 |
| Operating Profit Qtr Cr | 19 | 29 | 33 | 26 | 25 |
| Depreciation Qtr Cr | 7 | 7 | 6 | 7 | 4 |
| Interest Qtr Cr | 7 | 7 | 5 | 4 | 4 |
| Tax Qtr Cr | 1 | 4 | 6 | 4 | -1 |
| Net Profit Qtr Cr | 4 | 11 | 16 | 12 | 17 |
Bajaj Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹304.04
- 50 Day
- ₹315.47
- 100 Day
- ₹332.9
- 200 Day
- ₹349.36
- 20 Day
- ₹305.62
- 50 Day
- ₹311.36
- 100 Day
- ₹340.17
- 200 Day
- ₹363.13
Bajaj Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹299.92 |
| Second Resistance | ₹302.89 |
| Third Resistance | ₹305.77 |
| RSI | 34.08 |
| MFI | 27.02 |
| MACD Single Line | -4.96 |
| MACD | -5.8 |
| Support | |
|---|---|
| First Resistance | ₹294.07 |
| Second Resistance | ₹291.19 |
| Third Resistance | ₹288.22 |
Bajaj Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 49,065 | 3,424,737 | 69.8 |
| Week | 45,313 | 2,888,691 | 63.75 |
| 1 Month | 42,817 | 2,773,682 | 64.78 |
| 6 Month | 48,820 | 2,693,424 | 55.17 |
Bajaj Healthcare Result Highlights
Bajaj Healthcare Synopsis
NSE-Medical-Diversified
Bajaj Healthcare is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 673.29 Cr. and Equity Capital is Rs. 13.80 Cr. for the Year ended 31/03/2023. Bajaj Healthcare Ltd. is a Public Limited Listed company incorporated on 15/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1993PLC072892 and registration number is 072892.| Market Cap | 811 |
| Sales | 673 |
| Shares in Float | 0.91 |
| No of funds | 5 |
| Yield | 0.51 |
| Book Value | 2.21 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | 25 |
| Alpha | -0.03 |
| Beta | 0.71 |
Bajaj Healthcare
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 67.49% | 67.42% | 67.3% | 67.3% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.78% | 0.94% | 0.09% | 0.32% |
| Individual Investors | 16.44% | 16.67% | 16.5% | 16.71% |
| Others | 15.29% | 14.97% | 16.11% | 15.67% |
Bajaj Healthcare Management
| Name | Designation |
|---|---|
| Mr. Sajankumar R Bajaj | Chairman & Managing Director |
| Mr. Anil C Jain | Managing Director |
| Mr. Pakshal A Jain | Whole Time Director |
| Ms. Namrata S Bajaj | Whole Time Director |
| Mr. Dhananjay S Halte | Whole Time Director |
| Mr. Rupesh H Nikam | WholeTime Director & CFO |
| Mr. Ram B Banarase | Independent Director |
| Mr. Hemant R Karnik | Independent Director |
| Mr. Loukik D Tipnis | Independent Director |
| Mr. Avinash K Dalal | Independent Director |
| Mr. Luke B Fernandez | Independent Director |
| Ms. Kejal N Shah | Independent Director |
Bajaj Healthcare Forecast
Price Estimates
Bajaj Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-30 | Audited Results & Final Dividend | |
| 2023-02-13 | Quarterly Results | |
| 2022-11-11 | Quarterly Results | |
| 2022-08-12 | Quarterly Results | |
| 2022-05-17 | Audited Results & Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2021-09-29 | FINAL | Rs.0.50 per share(5%)Final Dividend |
| 2021-09-29 | SPECIAL | Rs.0.50 per share(5%)Special Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2021-09-29 | Split | Rs.0.00 split from Rs. 10/- to Rs. 5/-. |
Bajaj Healthcare FAQs
What is Share Price of Bajaj Healthcare ?
Bajaj Healthcare share price is ₹293 As on 08 June, 2023 | 03:22
What is the Market Cap of Bajaj Healthcare ?
The Market Cap of Bajaj Healthcare is ₹811.1 Cr As on 08 June, 2023 | 03:22
What is the P/E ratio of Bajaj Healthcare ?
The P/E ratio of Bajaj Healthcare is 18.9 As on 08 June, 2023 | 03:22
What is the PB ratio of Bajaj Healthcare ?
The PB ratio of Bajaj Healthcare is 2.2 As on 08 June, 2023 | 03:22